Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.

Tonmya (cyclobenzaprine HCl sublingual tablets) is now available for the treatment of adults with fibromyalgia, according to Tonix Pharmaceuticals.

Tonix Pharmaceuticals (NASDAQ:TNXP) saw its shares climb 8% on Monday after the company announced that TONMYA, its newly approved treatment for fibromyalgia, has officially launched in the U.S. and is ...

Following its FDA approval in the summer, Tonix Pharma's fibromyalgia therapy Tonmya has been launched onto the market in the US, becoming the first new drug for the painful condition in more than 16 ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology company, announced t ...

Tonix Pharmaceuticals Holding Corp. receives FDA nod for Tonmya, a breakthrough fibromyalgia treatment. Click here to find ...

People frequently wait years to be "taken seriously," postcode lotteries for access to care and a general lack of knowledge ...

A Delta Air Lines plane with 80 people on board crashed and flipped over on its side at Toronto Pearson International Airport in Canada. Fibromyalgia is a common syndrome in which a person has ...

Fibromyalgia is a condition that can cause various symptoms involving pain and fatigue. A rheumatologist may treat this condition alongside a full medical team. Members of the treatment team may ...

People suffering from the chronic pain condition fibromyalgia are being failed by the NHS, according to new research which found patients were waiting years for diagnosis, undergoing unnecessary tests ...

Another chronic condition called chronic fatigue syndrome (CFS), or myalgic encephalomyelitis, comprises a complex multisystem disease that is typically characterized by severe fatigue. 2 Both these ...

AKRON, Ohio — Would the FDA approve a drug for a disease that doesn’t exist? Though the most cynical among us might answer yes — anything to make a buck for a big pharmaceutical company — they’d say ...